Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant.
作者信息
Yamasoba Daichi, Uriu Keiya, Plianchaisuk Arnon, Kosugi Yusuke, Pan Lin, Zahradnik Jiri, Ito Jumpei, Sato Kei
机构信息
Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; Faculty of Medicine, Kobe University, Kobe, Japan.
Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; The Institute of Medical Science, and Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
出版信息
Lancet Infect Dis. 2023 Jun;23(6):655-656. doi: 10.1016/S1473-3099(23)00278-5. Epub 2023 May 3.
Abstract
摘要
相似文献
1
Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant.
Lancet Infect Dis. 2023 Jun;23(6):655-656. doi: 10.1016/S1473-3099(23)00278-5. Epub 2023 May 3.
2
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant.
Nat Commun. 2024 Feb 8;15(1):1176. doi: 10.1038/s41467-024-45274-3.
3
Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.
Med Sci Monit. 2023 Feb 1;29:e939580. doi: 10.12659/MSM.939580.
4
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
MMWR Morb Mortal Wkly Rep. 2023 Feb 3;72(5):119-124. doi: 10.15585/mmwr.mm7205e1.
5
Severity outcomes associated with SARS-CoV-2 XBB variants, an observational analysis.
J Clin Virol. 2023 Aug;165:105500. doi: 10.1016/j.jcv.2023.105500. Epub 2023 Jun 1.
6
SARS-CoV-2 variant omicron XBB.1.5: challenges and prospects - correspondence.
Int J Surg. 2023 Apr 1;109(4):1054-1055. doi: 10.1097/JS9.0000000000000276.
7
Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 - the public health challenges.
Int J Infect Dis. 2023 Mar;128:307-309. doi: 10.1016/j.ijid.2023.01.024. Epub 2023 Jan 19.
8
Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB.1.5, BQ.1, BQ.1.1, BF.7 and BA.2.75.2.
Signal Transduct Target Ther. 2023 Mar 15;8(1):125. doi: 10.1038/s41392-023-01391-x.
9
Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant.
Microbiol Spectr. 2022 Oct 26;10(5):e0192222. doi: 10.1128/spectrum.01922-22. Epub 2022 Sep 20.
10
Antigenic mapping of emerging SARS-CoV-2 omicron variants BM.1.1.1, BQ.1.1, and XBB.1.
Lancet Microbe. 2023 May;4(5):e294-e295. doi: 10.1016/S2666-5247(22)00384-6. Epub 2023 Jan 16.
引用本文的文献
1
2
Early detection of emerging SARS-CoV-2 Variants from wastewater through genome sequencing and machine learning.
Nat Commun. 2025 Jul 8;16(1):6272. doi: 10.1038/s41467-025-61280-5.
3
Enhanced reverse zoonotic potential and immune evasion by omicron JN.1 variant.
iScience. 2025 Jun 6;28(7):112824. doi: 10.1016/j.isci.2025.112824. eCollection 2025 Jul 18.
4
XBB.1.5 RBD-Based Bivalent Vaccines Induced Antibody Responses Against SARS-CoV-2 Variants in Mice.
Vaccines (Basel). 2025 May 20;13(5):543. doi: 10.3390/vaccines13050543.
5
A protein language model for exploring viral fitness landscapes.
Nat Commun. 2025 May 13;16(1):4236. doi: 10.1038/s41467-025-59422-w.
6
The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduced viral polymerase activity caused by mutations in NSP13 and NSP14.
J Virol. 2025 Jun 17;99(6):e0065625. doi: 10.1128/jvi.00656-25. Epub 2025 May 13.
7
Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients.
Sci Rep. 2025 May 6;15(1):15831. doi: 10.1038/s41598-025-98627-3.
8
Exploring Temporal and Spatial Characteristics of Serious Adverse Event Reports Following COVID-19 Bivalent Vaccines.
Res Sq. 2025 Mar 3:rs.3.rs-6096098. doi: 10.21203/rs.3.rs-6096098/v1.
9
Epimaps of the SARS-CoV-2 Receptor-Binding Domain Mutational Landscape: Insights into Protein Stability, Epitope Prediction, and Antibody Binding.
Biomolecules. 2025 Feb 18;15(2):301. doi: 10.3390/biom15020301.
10
Quantitative Characterization and Prediction of the Binding Determinants and Immune Escape Hotspots for Groups of Broadly Neutralizing Antibodies Against Omicron Variants: Atomistic Modeling of the SARS-CoV-2 Spike Complexes with Antibodies.
Biomolecules. 2025 Feb 8;15(2):249. doi: 10.3390/biom15020249.
Zotero 插件